Cardiovascular Systems (CSII) Prelim. Q1 Results Miss Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
Go back to Cardiovascular Systems (CSII) Prelim. Q1 Results Miss Expectations
October 8, 2015 7:45 AM EDT
BofA/Merrill Lynch downgraded Cardiovascular Systems (NASDAQ: CSII) from Buy to Underperform with a price target of $15.00.
For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.
Shares of Cardiovascular Systems closed at $16.63 yesterday.
...
More
October 8, 2015 7:37 AM EDT
Needham & Company downgraded Cardiovascular Systems (NASDAQ: CSII) from Strong Buy to Buy with a price target of $18.00 (from $37.00).
Analyst Mike Matson commented, "We are downgrading CSII to Buy from Strong Buy after last night's negative preannouncement. On one hand, we see... More
October 8, 2015 6:24 AM EDT
Leerink Partners downgraded Cardiovascular Systems (NASDAQ: CSII) from Outperform to Market Perform with a price target of $17.00 (from $45.00) after the company preannounced weaker-than-expected F1Q16 sales driven by another quarter of salesforce disruption.
Analyst Danielle Antalffy commented, "Clearly the salesforce transition... More
